Loading…

Serán Bioscience announced a growth investment led by Biospring Partners to accelerate expansion of its clinical-to-commercial services. A new greenfield commercial manufacturing facility in Bend, Oregon is on track for completion in Q3 2027, creating a 200,000+ sq. ft. campus.
“The new capital commitment underscores Serán’s sustained commercial momentum and business success.”seranbio.com
Summarized from public sources; check the original articles before acting on it.